as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
8.13%
Downside
1.79%
Upside
52 Week's Low
52 Week's High
67.35%
Downside
53.08%
Upside
Check Rapt Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$268.2M
EPS (TTM)
-1.9599
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-112.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
14735600.00%
Compare market cap, revenue, PE, and other key metrics of Rapt Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $268.2M | -94.43% | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Rapt Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rapt Therapeutics Inc investment value today
Current value as on today
₹1,16,203
Returns
₹16,203
(+16.2%)
Returns from Rapt Therapeutics Inc Stock
₹11,218 (+11.22%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 17 analysts
64.71%
Buy
35.29%
Hold
0.00%
Sell
Based on 17 analysts, 64.71% of analysts recommend a 'BUY' rating for Rapt Therapeutics Inc. Average target price of $23.6
Get share price movements and forecasts by analysts on Rapt Therapeutics Inc.
What analysts predicted
26.48%UPSIDE
Target Price
$23.6
Current Price
$17.35
Analyzed by
17 Analysts
Target
$23.60
Rapt Therapeutics Inc target price $23.6, a slight upside of 26.48% compared to current price of $17.35. According to 17 analysts rating.
Search interest for Rapt Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, RAPT stock has moved up by 28.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 207.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 54.8%
Organisation | Rapt Therapeutics Inc |
Headquarters | 561 Eccles Avenue, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Brian Russell Wong M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Rodney K. B. Young | CFO, Principal Accounting Officer & Secretary |
Dr. William Ho M.D., Ph.D. | Chief Medical Officer |
Steve Young Ph.D. | Vice President of Technology |
Dr. Paul Kassner Ph.D. | Senior Vice President of Biology |
Dr. Nipun Davar MBA, Ph.D. | Senior Vice President of Technical Operations |
Dr. Brian Russell Wong M.D., Ph.D. | CEO, President & Director |
Dr. Dirk G. Brockstedt Ph.D. | Chief Scientific Officer |
Mr. Michael Listgarten | General Counsel |
Ms. Gwen R. Carscadden | Chief Human Resources Officer |
Ms. Jennifer Nicholson | Senior Vice President of Regulatory Affairs & Quality Assurance |
Rapt Therapeutics Inc share price today is $17.35 as on at the close of the market. Rapt Therapeutics Inc share today touched a day high of $17.66 and a low of $15.94.
Rapt Therapeutics Inc share touched a 52 week high of $26.56 on and a 52 week low of $5.67 on . Rapt Therapeutics Inc stock price today i.e. is closed at $17.35,which is 34.68% down from its 52 week high and 206.26% up from its 52 week low.
Rapt Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rapt Therapeutics Inc (RAPT) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Rapt Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rapt Therapeutics Inc share’s latest price of $17.35 as on September 16, 2025 at 1:29 am IST, you will get 0.5764 shares of Rapt Therapeutics Inc. Learn more about
fractional shares .
Rapt Therapeutics Inc stock has given -94.43% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?